The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials

Autor: Wheatley-Price, P. ^*, Blackhall, F., Lee, S.-M., Ma, C., Ashcroft, L., Jitlal, M., Qian, W., Hackshaw, A., Rudd, R., Booton, R., Danson, S., Lorigan, P., Thatcher, N., Shepherd, F.A.

Publikováno v: In Annals of Oncology October 2010 21(10):2023-2028

Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population.

Autor: Simonet C; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Neurology, Royal London Hospital, London, United Kingdom., Bestwick J; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Jitlal M; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Food Standards Agency, London, United Kingdom., Waters S; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Ben-Joseph A; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Marshall CR; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Neurology, Royal London Hospital, London, United Kingdom., Dobson R; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Neurology, Royal London Hospital, London, United Kingdom., Marrium S; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Robson J; Centre for Primary Care, Wolfson Institute of Population Health, The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Jacobs BM; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Neurology, Royal London Hospital, London, United Kingdom., Belete D; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Lees AJ; Reta Lila Weston Institute, Institute of Neurology, UCL and National Hospital, Queen Square, London, United Kingdom., Giovannoni G; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Neurology, Royal London Hospital, London, United Kingdom.; Blizard Institute, Queen Mary University of London, London, United Kingdom., Cuzick J; Centre for Cancer Prevention, Queen Mary University of London, London, United Kingdom., Schrag A; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Clinical and Movement Neuroscience, University College London Queen Square Institute of Neurology, London, United Kingdom., Noyce AJ; Preventive Neurology Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Neurology, Royal London Hospital, London, United Kingdom.; Department of Clinical and Movement Neuroscience, University College London Queen Square Institute of Neurology, London, United Kingdom.

Publikováno v: JAMA neurology [JAMA Neurol] 2022 Apr 01; Vol. 79 (4), pp. 359-369.

Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm.

Autor: Bestwick JP; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Auger SD; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Simonet C; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Rees RN; Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK., Rack D; Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK., Jitlal M; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Giovannoni G; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK., Lees AJ; Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK., Cuzick J; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Schrag AE; Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK., Noyce AJ; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. a.noyce@qmul.ac.uk.; Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK. a.noyce@qmul.ac.uk.

Publikováno v: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2021 Apr 01; Vol. 7 (1), pp. 33. Date of Electronic Publication: 2021 Apr 01.

CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma.

Autor: Loo, Suet Kee^1,2 (AUTHOR), Sica, Gabriel^3,4 (AUTHOR), Wang, Xian^1,2 (AUTHOR), Li, Tingting^1,2 (AUTHOR), Chen, Luping^1,2 (AUTHOR), Gaither-Davis, Autumn⁵ (AUTHOR), Huang, Yufei^1,5,6 (AUTHOR), Burns, Timothy F.^5,7,8 (AUTHOR), Stabile, Laura P.^7,8 (AUTHOR), Gao, Shou-Jiang^1,2 (AUTHOR) gaos8@upmc.edu

Publikováno v: Cell & Bioscience. 10/9/2024, Vol. 14 Issue 1, p1-14. 14p.

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

Autor: Glynne-Jones, R, Hava, N, Goh, V, Bosompem, S, Bridgewater, J, Chau, I, Gaya, A, Wasan, H, Moran, B, Melcher, L, MacDonald, A, Osborne, M, Beare, S, Jitlal, M, Lopes, A, Hall, M, West, N, Quirke, P, Wong, W-L, Harrison, M, Bacchus investigators

Background In locally advanced rectal cancer (LARC) preoperative chemoradiation (CRT) is the standard of care, but the risk of local recurrence is low with good quality total mesorectal excision (TME), although many still develop metastatic disease.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::fac1ecf79f4119e6cb081ddac78e6d15